XWXiaojing Wang

Xiaojing Wang

*This is an algorithmically generated author record based on publicly available information.

Xiaojing Wang has a total of 38 co-authors. Here are the top co-authors by number of shared publications:

  • Min Nie

    NHC Key Laboratory of Endocrinology (Peking Union Medical College Hospital), Department of Endocrinology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences , Beijing 100730

    3 shared publications
  • Fan Ping

    Department of Endocrinology, Key Laboratory of Endocrinology of National Health Commission, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

    2 shared publications
  • Juntao Liu

    Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, 100730, China

    2 shared publications
  • Liangkun Ma

    Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, 100730, China

    2 shared publications
  • Wei Li

    Key Laboratory of Endocrinology of National Health Commission, Department of Endocrinology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China

    2 shared publications
  • Anli Tong

    NHC Key Laboratory of Endocrinology (Peking Union Medical College Hospital), Department of Endocrinology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences , Beijing 100730

    1 shared publication

Latest Publications

  • Open Access

    Atypical Hypoglycemia-Induced Stroke Mimic: A Case Report and Literature Review

    by TianTian Zhang, LiXia Jin, WenHui Zhao, JianZhong Xiao, XiaoJing Wang

    This case describes an uncommon presentation of a hypoglycemia-related stroke mimic in a patient with poorly controlled type 2 diabetes, in whom acute neurological symptoms developed despite a blood glucose level above the conventional hypoglycemic threshold. A 72-year-old woman presented with acute fatigue, drowsiness, and dysarthria after initiation of an intensified glucose-lowering regimen. Her blood glucose level was 4.1 mmol/L at symptom onset and increased after glucose administration; however, her neurological symptoms persisted. Because acute ischemic stroke could not be confidently excluded during the emergency evaluation, intravenous alteplase was administered. Her symptoms subsequently improved approximately 9.5 hours after symptom onset. Comprehensive neurovascular and brain imaging, including computed tomography, computed tomography angiography, magnetic resonance imaging, and transcranial Doppler ultrasonography, showed no evidence of acute ischemic lesions or significant vascular occlusion. After adjustment of her glucose-lowering therapy, her neurological condition remained stable, and no permanent neurological deficits were observed. This case highlights the diagnostic challenge of distinguishing hypoglycemia-related stroke mimic from acute ischemic stroke, particularly in patients with poorly controlled diabetes and fluctuating glucose levels. It also suggests that relative or rapidly declining glucose levels may contribute to stroke-like neurological symptoms even when absolute glucose values do not meet the conventional definition of hypoglycemia. Careful clinical assessment, timely glucose measurement, and urgent stroke evaluation remain essential when acute ischemic stroke cannot be reliably excluded.

  • Open Access

    The Association Between Serum Vitamin D Status and Cardiometabolic Risk Factors in Extremely Obese Adults: A Cross‐Sectional Study

    by Yan Zhou, Chunyan Wang, Zhixing Wang, Xiaojing Wang

    Background: Vitamin D may play a vital role in glucose and lipid metabolism, but existing studies on this topic are limited and inconsistent. The aim of our study was to undertake an in depth exploration of the relationship between vitamin D and cardiometabolic markers in extremely obese individuals in North China. Methods: In this cross‐sectional study, 293 adults aged between 18 and 60 years with BMIs higher than 35 kg/m 2 were recruited from Beijing, China. Serum 25(OH) D was measured using chemiluminescence, and concentrations of glucose, insulin, and lipids were quantified as well. Multiple linear regression analysis adjusted for potential confounding factors was used to assess independent associations between serum 25(OH) D and lipid profiles. Results: The prevalence of vitamin D deficiency was 81.2% in the extremely obese subjects, and the median serum 25(OH) D concentration was 12.88 ng/mL. Moreover, 25(OH) D levels were significantly negatively associated with the BMI and parathyroid hormone ( p < 0.0001). After adjustment for age, sex, BMI, and HOMA‐IR, 25(OH) D levels were positively correlated with HDL‐c ( p < 0.007) and ApoA1 as well ( p < 0.001). No significant differences in blood pressure, fasting blood glucose, or HOMA‐IR were detected between vitamin D nondeficient (≥ 20 ng/mL) and deficient (< 20 ng/mL) groups. Conclusions: Vitamin D deficiency is highly prevalent in extremely obese individuals in China, exhibiting significant correlations with higher BMI and lower HDL‐c/ApoA1. Our findings underscore the importance of vitamin D deficiency as a correlate of cardiovascular risk. Prospective studies and randomized clinical trials are warranted to determine the effect of 25(OH) D on other cardiometabolic parameters.


  • Open Access

    Alterations in the Gut Microbiota Composition in Obesity with and without Type 2 Diabetes: A Pilot Study

    by Xiaojing Wang, Qinli Guo, Zhaoxiang Liu, Yanlei Wang, Chenxiang Cao, Lixia Jin, Caihong Li, Jianzhong Xiao, Wenhui Zhao

    Purpose: Obesity has become a major public health concern worldwide, increasing the risk of T2DM. Growing evidence indicates gut microbiota dysbiosis is related to metabolic disorders. We aimed to firstly investigate the compositional and functional features of the gut microbiome between obesity with and without T2DM in the Chinese population. Methods: A total of 32 obese individuals accompanied with T2DM and 18 age and gender-matched obesity with normal glucose tolerance (NGT) were enrolled. Fecal samples were collected, and the gut microbiota profile was determined using the Illumina MiSeq platform based on V3-V4 bacterial 16S rRNA gene. Results: Compared with obesity- NGT, obesity-T2DM showed a significantly higher alpha diversity. Principal coordinates analysis based on both Bray-Curtis distance and weighted Unifrac revealed that the global microbial composition was significantly different between the two groups (P = 0.007 and P = 0.005, respectively). At the phylum level, Obesity-T2DM patients exhibited a significant decrease in Bacteroidetes, and a pronounced increase in Firmicutes. Regarding the genus level, Bacteroides and Escherichia-Shigella were found to increase considerably, while Prevotella_9 and Sutterella had an evident decrease in Obesity-T2DM. Furthermore, Spearman correlation analysis revealed that Prevotella_9 and Sutterella were negatively associated with HbA1c and fasting blood glucose. Conclusion: We found clear differences in the gut microbiota composition in obesity-T2DM compared with obesity-NGT. Obesity accompanied with T2DM may aggravate the obesity-associated gut microbiota, and gut microbiota is expected to be a promising novel intervention target for obese management. However, larger sample size and more in-depth taxonomic identification studies are warranted.


  • Investigation of miRNA-binding site variants and risk of gestational diabetes mellitus in Chinese pregnant women

    by Xiaojing Wang, Wei Li, Liangkun Ma, Fan Ping, Juntao Liu, Xueyan Wu, Jiangfeng Mao, Xi Wang, Min Nie

    Aims Emerging evidence suggested genetic factor attributed as a major determinant for the complex pathogenic mechanism of gestational diabetes mellitus (GDM), but the related genetic study was limited. We aimed to investigate the impact of polymorphisms in miRNA-binding sites (miR-binding SNPs) on the risk of GDM in Chinese Han pregnant women. Methods We screened GDM susceptibility genes extensively and selected miR-binding SNPs using four bioinformatics software. TaqMan allelic discrimination assays were applied to miR-binding SNPs genotyping in 839 GDM patients and 900 controls. Results In total five potential miR-binding SNPs (SLC30A8 rs2466293, INSR rs1366600, INSR rs3745550, KCNJ11 rs5210 and KCNQ1 rs8234) were selected. Our results showed that SLC30A8 rs2466293 [OR 95% CI = 1.455 (1.077, 1.966); P = 0.014] and INSR rs1366600 [OR 95% CI = 2.191 (1.077, 4.455); P = 0.029] increased the risk of GDM after adjusting age in additive model. Furthermore, rs2466293 was found to significantly associate with higher levels of fasting plasma glucose (b dom = 0.054, P dom = 0.032), 2-h OGTT plasma glucose (b dom = 0.069, P dom = 0.007), lower fasting insulin concentrations (b rec = −0.082, P rec = 0.003) and decreased HOMA-B (b rec = −0.067, P rec = 0.015). Additionally, the correlation between rs1366600 and 2-h OGTT plasma glucose (b dom = 0.078, P dom = 0.001) was observed. Conclusions Two miR-binding SNPs SLC30A8 rs2466293 and INSR rs1366600 increased GDM susceptibility. Functional studies were required to confirm the underlying mechanism. Our study provided additional insights into the genetic pathogenesis of GDM.


  • Open Access

    Associating Multivariate Quantitative Phenotypes with Genetic Variants in Family Samples with a Novel Kernel Machine Regression Method

    by Qi Yan, Daniel E Weeks, Juan C. Celedón, Hemant K. Tiwari, Bingshan Li, Xiaojing Wang, Wan-Yu Lin, Xiang-Yang Lou, Guimin Gao, Wei Chen, et al.

    The recent development of sequencing technology allows identification of association between the whole spectrum of genetic variants and complex diseases. Over the past few years, a number of association tests for rare variants have been developed. Jointly testing for association between genetic variants and multiple correlated phenotypes may increase the power to detect causal genes in family-based studies, but familial correlation needs to be appropriately handled to avoid an inflated type I error rate. Here we propose a novel approach for multivariate family data using kernel machine regression (denoted as MF-KM) that is based on a linear mixed-model framework and can be applied to a large range of studies with different types of traits. In our simulation studies, the usual kernel machine test has inflated type I error rates when applied directly to familial data, while our proposed MF-KM method preserves the expected type I error rates. Moreover, the MF-KM method has increased power compared to methods that either analyze each phenotype separately while considering family structure or use only unrelated founders from the families. Finally, we illustrate our proposed methodology by analyzing whole-genome genotyping data from a lung function study.


  • Association study of the miRNA-binding site polymorphisms of CDKN2A/B genes with gestational diabetes mellitus susceptibility

    by Xiaojing Wang, Wei Li, Liangkun Ma, Jinsong Gao, Juntao Liu, Fan Ping, Min Nie

    Gestational diabetes mellitus (GDM) is a complex disease induced by a combination of genetic factors and environmental exposures. Growing evidence suggests that common single nucleotide polymorphisms within miRNA-binding sites (miR-binding SNPs) contribute to the development of various diseases. However, the roles of miR-binding SNPs in GDM have not been fully elucidated. The CDKN2A/B genes have been identified as two of the strongest genetic determinants for diabetes risk. The aim of the study was to first investigate the associations between miR-binding SNPs of CDKN2A/B, GDM susceptibility, and quantitative metabolism traits.Three miR-binding SNPs of CDKN2A/B gene (rs1063192, rs3217992, and rs3088440) were selected and genotyped using TaqMan allelic discrimination assays in 839 cases of GDM and 900 controls.The CC genotype of CDKN2B rs1063192, which is located in the hsa-miR-323b-5p binding site, was significantly associated with GDM [OR 1.418 (1.143, 1.908); p = 0.003]. The C allele of rs1063192 occurred with significantly higher frequency in GDM [OR 1.22 (1.03, 1.44); p = 0.021]. The rs1063192 genotype CC exhibited increased glucose levels at 1 h and 3 h, as well as higher insulin levels at 3 h during an OGTT compared with the control TT genotype (p < 0.05). We also found that the rs1063192 CC genotype was associated with lower total cholesterol and LDL cholesterol levels (p < 0.05).The CC genotype of CDKN2B rs1063192 in the hsa-miR-323b-5p binding site increased the risk of GDM in pregnant Chinese Han women. Importantly, our study provides evidence that miR-binding SNPs are a novel source of GDM susceptibility loci.